Two months post-acquisition, BPGbio has signed a new, five-year partnership with the Department of Defense and laid out a near-term plan to get to the public markets.

By Rowan Walrath – Life Sciences Reporter, Boston Business Journal With just one partnership, Framingham bioanalytics firm Berg Health LLC is going from a small Massachusetts company to a global firm. At least, that’s how CEO and co-founder Niven Narain sees it. His company has just signed a first-ofits- kind partnership with Microsoft to integrate…

The clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option. Click here to view the full article at Outsourcing-Pharma.com.

The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations. Click here to view the full article at Outsourcing-Pharma.com.

In an October 6, 2020 Forbes.com column, Robert Reiss, Contributor Leadership Strategy moderated what he believes to be a key step in the pioneering of a new collaborative drug development model. The new series called, the BERG Healthcare Exchange, which will occur quarterly, will focus on key issues and trends impacting the future of healthcare…

Results from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent. Click here to view the full article at Outsourcing-Pharma.com.